1
|
Witztum J, Gaudet D, Freedman S, Alexander V, Arca M, Stroes E, Bergeron J, Soran H, Civeira F, Tsimikas S, Blom D, Bruckert E. Effects of patient characteristics on volanesorsen efficacy: Subgroup analysis of approach. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
2
|
Casula M, Olmastroni E, Gazzotti M, Arca M, Averna M, Catapano A. LDL-cholesterol levels and LDL polygenic score in a cohort of patients with clinically diagnosed familial hypercholesterolemia. Data from the LIPIGEN study. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
3
|
Cefalù A, D'Erasmo L, Giammanco A, Montali A, Iannuzzo G, Zambon A, Forte F, Noto D, Suppressa P, Giannini S, Arca M, Averna M. Lomitapide effectively reduces triglyceride (TG) levels in familial chylomicronemia syndrome (FCS). Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
4
|
Bini S, Pecce V, D'Erasmo L, Di Costanzo A, Minicocci I, Arca M. ANGPTL3 and PCSK9 interact and show coordinated metabolic regulation in vitro. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
Minicocci I, Ossoli A, Turri M, D'Erasmo L, Di Costanzo A, Bini S, Veglia F, Calabresi L, Arca M. The genetic lack of ANGTPL3 does not alter HDL functionality. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
6
|
Di Costanzo A, Baratta F, D'Erasmo L, Umbro I, Colantoni A, Cocomello N, Pastori D, Arca M, Angelico F, Del Ben M. Role of NAFLD-associated genetic variants on renal function in patients with nonalcoholic fatty liver disease. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
7
|
Steward K, Van Lennep JER, Arca M, Boersma E, Di Constanzo A, D'Erasmo L. Evaluation of the real-world efficacy effectiveness and safety of lomitapide in the management of HoFH: The European experience study. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Scicali, D'Erasmo L, Cluzel P, Redheuil A, Di Pino A, Rabuazzo A, Piro S, Arca M, Purrello F, Bruckert E, Gallo A. High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Olmastroni E, Gazzotti M, Arca M, Averna M, Casula M, Catapano A. Evaluating the distribution of A 12 LDL-C raising variants score in patients with familial hypercholesterolemia. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Bini S, Pecce V, Arca M. ANGPTL3 and PCSK9 interaction and modulation in feeding and fasting conditions using HEPG2 cellular model. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Casula M, Gazzotti M, Bonaiti F, OImastroni E, Arca M, Averna M, Zambon A, Catapano AL. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. J Intern Med 2021; 290:116-128. [PMID: 33259671 PMCID: PMC8359216 DOI: 10.1111/joim.13219] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 10/14/2020] [Accepted: 11/05/2020] [Indexed: 12/31/2022]
Abstract
AIM Statin-associated muscle symptoms (SAMS) are a major determinant of poor treatment adherence and/or discontinuation, but a definitive diagnosis of SAMS is challenging. The PROSISA study was an observational retrospective study aimed to assess the prevalence of reported SAMS in a cohort of dyslipidaemic patients. METHODS Demographic/anamnestic data, biochemical values and occurrence of SAMS were collected by 23 Italian Lipid Clinics. Adjusted logistic regression was performed to estimate odds ratio (OR) and 95% confidence intervals for association between probability of reporting SAMS and several factors. RESULTS Analyses were carried out on 16 717 statin-treated patients (mean ± SD, age 60.5 ± 12.0 years; 52.1% men). During statin therapy, 9.6% (N = 1599) of patients reported SAMS. Women and physically active subjects were more likely to report SAMS (OR 1.23 [1.10-1.37] and OR 1.35 [1.14-1.60], respectively), whist age ≥ 65 (OR 0.79 [0.70-0.89]), presence of type 2 diabetes mellitus (OR 0.62 [0.51-0.74]), use of concomitant nonstatin lipid-lowering drugs (OR 0.87 [0.76-0.99]), use of high-intensity statins (OR 0.79 [0.69-0.90]) and use of potential interacting drugs (OR 0.63 [0.48-0.84]) were associated with lower probability of reporting SAMS. Amongst patients reporting SAMS, 82.2% underwent dechallenge (treatment interruption) and/or rechallenge (change or restart of statin therapy), with reappearance of muscular symptoms in 38.4% (3.01% of the whole cohort). CONCLUSIONS The reported prevalence of SAMS was 9.6% of the whole PROSISA cohort, but only a third of patients still reported SAMS after dechallenge/rechallenge. These results emphasize the need for a better management of SAMS to implement a more accurate diagnosis and treatment re-evaluation.
Collapse
Affiliation(s)
- M Casula
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.,IRCCS MultiMedica, Milan, Italy
| | - M Gazzotti
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
| | - F Bonaiti
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
| | - E OImastroni
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
| | - M Arca
- Department of Translational and Precision Medicine, Unit of Internal Medicine and Metabolic Diseases, Sapienza University, Rome, Italy
| | - M Averna
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities, University of Palermo, Palermo, Italy
| | - A Zambon
- IRCCS MultiMedica, Milan, Italy.,Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - A L Catapano
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.,IRCCS MultiMedica, Milan, Italy
| | | |
Collapse
|
12
|
D'Erasmo L, Maranghi M, Brancato F, Stanca I, Montali A, Pigna G, Francone M, Ascione A, Arca M. Atherosclerotic coronary artery disease burden by ct scan in subjects with molecularly defined heterozygous familial hypercolesterolemia (HEFH), polygenic familial hypercholesterolemia (PFH) and controls: A pilot study. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Di Costanzo A, Ronca A, D'Erasmo L, Manfredini M, Baratta F, Pastori D, Polito L, Di Martino M, Angelico F, Del Ben M, Favari E, Arca M. Impaired HDL cholesterol efflux capacity in subjects with metabolically- but not genetically- driven non-alcoholic fatty liver disease (NAFLD). Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
14
|
Polito L, Ghadiri A, Di Costanzo A, Arca M. Effects Of Angptl3 In C2C12 Muscle Cells: Results Of A Preliminary Study. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Arca M, Soran H, Digenio A, Hsieh A, Rosenblit P, Stevenson M. Assessing the disease burden among patients with familial chylomicronemia syndrome (FCS) on volanesorsen: Results of the re-focus study. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
D'erasmo L, Di Costanzo A, Cassandra F, Minicocci I, Polito L, Arca M. Detection of familial chylomicronemia syndrome in a cohort of patients with severe hypertriglyceridemia through a next generation sequencing approach. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Perucci CA, Rapiti E, Davoli M, Lagorio S, Arca M, Miller AB. Rome Women's Screening Study: Knowledge, Attitudes and Practices of Women regarding Screening for Breast and Cervical Cancer. Tumori 2018; 76:365-9. [DOI: 10.1177/030089169007600412] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
| | | | - Marina Davoli
- Epidemiology Unit, Latium Regional Health Authority, Rome
| | | | - Massimo Arca
- Epidemiology Unit, Latium Regional Health Authority, Rome
| | - Anthony B. Miller
- Department of Preventive Medicine and Biostatistics, University of Toronto, Canada
| |
Collapse
|
18
|
Arca M, Borghi C, Pontremoli R, De Ferrari GM, Colivicchi F, Desideri G, Temporelli PL. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention. Nutr Metab Cardiovasc Dis 2018; 28:197-205. [PMID: 29397253 DOI: 10.1016/j.numecd.2017.11.001] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/10/2017] [Revised: 10/12/2017] [Accepted: 11/06/2017] [Indexed: 01/12/2023]
Abstract
AIMS This review aims to describe the pathogenic role of triglycerides in cardiometabolic risk, and the potential role of omega-3 fatty acids in the management of hypertriglyceridemia and cardiovascular disease. DATA SYNTHESIS In epidemiological studies, hypertriglyceridemia correlates with an increased risk of cardiovascular disease, even after adjustment for low density lipoprotein cholesterol (LDL-C) levels. This has been further supported by Mendelian randomization studies where triglyceride-raising common single nucleotide polymorphisms confer an increased risk of developing cardiovascular disease. Although guidelines vary in their definition of hypertriglyceridemia, they consistently define a normal triglyceride level as <150 mg/dL (or <1.7 mmol/L). For patients with moderately elevated triglyceride levels, LDL-C remains the primary target for treatment in both European and US guidelines. However, since any triglyceride level in excess of normal increases the risk of cardiovascular disease, even in patients with optimally managed LDL-C levels, triglycerides are an important secondary target in both assessment and treatment. Dietary changes are a key element of first-line lifestyle intervention, but pharmacological treatment including omega-3 fatty acids may be indicated in people with persistently high triglyceride levels. Moreover, in patients with pre-existing cardiovascular disease, omega-3 supplements significantly reduce the risk of sudden death, cardiac death and myocardial infarction and are generally well tolerated. CONCLUSIONS Targeting resistant hypertriglyceridemia should be considered as a part of clinical management of cardiovascular risk. Omega-3 fatty acids may represent a valuable resource to this aim.
Collapse
Affiliation(s)
- M Arca
- Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Roma, Italy.
| | - C Borghi
- Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Ospedale Policlinico S.Orsola-Malpighi, Bologna, Italy
| | - R Pontremoli
- Dipartimento di Medicina Interna, Università di Genova, Ospedale Policlinico San Martino, Genova, Italy
| | - G M De Ferrari
- Unità Coronarica e Laboratori Sperimentazione e Ricerca, Centro Clinico di Ricerca Cardiovascolare, IRCCS Fondazione Policlinico San Matteo, Dipartimento di Medicina Molecolare, Università degli Studi di Pavia, Pavia, Italy
| | - F Colivicchi
- UOC Cardiologia, Ospedale S. Filippo Neri, ASL ROMA 1, Roma, Italy
| | - G Desideri
- Facoltà di Medicina e Chirurgia, Università degli Studi dell'Aquila, L'Aquila, Italy
| | - P L Temporelli
- Divisione di Cardiologia Riabilitativa, ICS Maugeri, IRCCS, Veruno-NO, Italy
| |
Collapse
|
19
|
Poggiogalle E, Fontana M, Minicocci I, Montali A, Ceci F, Di Costanzo A, Rosano A, Arca M, Lenzi A, Donini L. SUN-P001: Effects of Angiopoietin-Like Protein 3 Deficiency on Respiratory Quotient and Energy Expenditure after an Oral Fat Tolerance Test. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30344-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Sentinelli F, Bertoccini L, Barchetta I, Capoccia D, Incani M, Pani MG, Loche S, Angelico F, Arca M, Morini S, Manconi E, Lenzi A, Cossu E, Leonetti F, Baroni MG, Cavallo MG. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children. Nutr Metab Cardiovasc Dis 2016; 26:407-413. [PMID: 27052925 DOI: 10.1016/j.numecd.2016.02.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 12/30/2015] [Accepted: 02/01/2016] [Indexed: 01/21/2023]
Abstract
BACKGROUND AND AIMS 1α,25-dihydroxyvitamin-D3, the biologically active vitamin D, plays a central role in several metabolic pathways through the binding to the vitamin D receptor (VDR). VDR has been shown to be involved in cardiovascular diseases, cancer, autoimmunity and type 2 diabetes mellitus (T2DM). Several polymorphisms in the VDR gene have been described. Among these, the rs11568820 G-to-A nucleotide substitution was found to be functional, modulating the transcription of the VDR gene. Objective of this study was to perform an association study between rs11568820 polymorphism and T2DM in a cohort of Italian adults with T2DM and in non-diabetic controls. To add further insight into the role of VDR gene we explored whether this association begins early in life in overweight/obese children, or becomes manifest only in adulthood. METHODS AND RESULTS As many as 1788 adults and 878 children were genotyped for the rs11568820 polymorphism. All participants underwent oral glucose tolerance tests (OGTT), with measurement of glucose and insulin levels. Indices of insulin-resistance and secretion were also calculated. The AA genotype was significantly more frequent in adults with T2DM compared to controls (7.5% vs. 4.6%, P = 0.037), and conferred a higher risk of T2DM (ORHom = 1.69C.I. = [1.13-2.53], P = 0.011). In the adult cohort, rs11568820 was also associated with reduced indices of β-cell insulin secretion. In children, the AA genotype was associated with 2 h high-normal glucose, a marker of cardio-metabolic risk. CONCLUSIONS Our study demonstrates for the first time that VDR gene AA carriers have higher risk of T2DM and impaired insulin secretion. In children, the association between AA homozygous and high-normal 2h glucose suggests that mild alterations associated with this genotype may appear early in life.
Collapse
Affiliation(s)
- F Sentinelli
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - L Bertoccini
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - I Barchetta
- Internal Medicine Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy
| | - D Capoccia
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - M Incani
- Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
| | - M G Pani
- Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
| | - S Loche
- Pediatric Endocrine Unit, Regional Hospital for Microcitemia, Cagliari, Italy
| | - F Angelico
- Internal Medicine Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy
| | - M Arca
- Internal Medicine Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy
| | - S Morini
- Human Anatomy, (CIR), University Campus Bio-Medico, Rome, Italy
| | - E Manconi
- Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
| | - A Lenzi
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - E Cossu
- Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
| | - F Leonetti
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - M G Baroni
- Department of Experimental Medicine, Sapienza University of Rome, Italy; Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.
| | - M G Cavallo
- Internal Medicine Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy
| |
Collapse
|
21
|
Lachowicz JI, Nurchi VM, Crisponi G, Jaraquemada-Pelaez MG, Arca M, Pintus A, Santos MA, Quintanova C, Gano L, Szewczuk Z, Zoroddu MA, Peana M, Domínguez-Martín A, Choquesillo-Lazarte D. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one. Dalton Trans 2016; 45:6517-28. [DOI: 10.1039/c6dt00129g] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
an tautomeric changes positively influence coordinating ability?
Collapse
|
22
|
Di Costanzo A, D'Erasmo L, Polimeni L, Loffredo L, Coletta P, Del Ben M, Angelico F, Montali A, Girelli G, De Masi B, Maranghi M, Arca M. Is fatty liver an independent risk factor for subclinical atherosclerosis? Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Del Ben M, Polimeni L, Brancorsini M, Di Costanzo A, D'Erasmo L, Baratta F, Loffredo L, Pastori D, Pignatelli P, Violi F, Arca M, Angelico F. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. Eur J Intern Med 2014; 25:566-70. [PMID: 24947770 DOI: 10.1016/j.ejim.2014.05.012] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2014] [Revised: 05/10/2014] [Accepted: 05/23/2014] [Indexed: 12/17/2022]
Abstract
BACKGROUND & AIMS Non-alcoholic fatty liver disease was traditionally interpreted as a condition which may progress to liver-related complications. However, the increased mortality is primarily a result of cardiovascular diseases. It has been suggested that fatty liver can be considered as the hepatic consequence of the metabolic syndrome. The aim was to describe the different clinical presentations of non-alcoholic fatty liver disease on the basis of the patatin-like phospholipase domain-containing protein3 (PNPLA3) rs738409 gene variant. METHODS Fatty liver was defined by ultrasonographic Hamaguchi's criteria in 211 consecutive subjects with non-alcoholic fatty liver disease. The rs738409 polymorphism was determined by TaqMan assays. Metabolic syndrome was defined according to ATPIII modified criteria. RESULTS Prevalence of PNPLA3-148II, PNPLA3-148IM, and PNPLA3-148MM genotypes was 45.0%, 40.7%, and 14.3% respectively. Prevalence of metabolic syndrome progressively increased with the severity of liver steatosis (from 52.5% to 65.2%, and 82.3% respectively, p<0.01). The PNPLA3-148MM group had significantly lower mean serum triglycerides (p<0.001), Framingham cardiovascular risk score (p<0.01) and lower prevalence of metabolic syndrome (p<0.05) and its components. Age and HOMA-IR were positive independent predictors of metabolic syndrome, while a negative independent association was found between metabolic syndrome and the homozygotes PNPLA3 I148M variant. CONCLUSIONS We suggest a lower prevalence of MetS and reduced cardiovascular risk in NAFLD patients with PNPLA3MM genotype.
Collapse
Affiliation(s)
- M Del Ben
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - L Polimeni
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - M Brancorsini
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - A Di Costanzo
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - L D'Erasmo
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - F Baratta
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - L Loffredo
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - D Pastori
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - P Pignatelli
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - F Violi
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - M Arca
- Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy
| | - F Angelico
- Department of Public Health and Infectious Disease, Sapienza University, Rome, Italy.
| |
Collapse
|
24
|
Arca M, Zhang Y, Wittner M, Louache F, Solary E, Coppo P. SFP CO-61 - Etude du rôle de l’interféron-gamma dans le syndrome hémophagocytaire des hémopathies lymphoïdes. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71899-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Crespo Alonso M, Arca M, Isaia F, Lai R, Lippolis V, Callear SK, Caricato M, Pasini D, Coles SJ, Aragoni MC. Stereospecific generation of homochiral helices in coordination polymers built from enantiopure binaphthyl-based ligands. CrystEngComm 2014. [DOI: 10.1039/c4ce01101e] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
The novel enantiopure spacer 2,2′-dimethoxy-1,1′-binaphthyl-3,3′-bis(4-pyridyl-amido) has been designed to prepare helical coordination polymers here investigated by means of experimental and theoretical data.
Collapse
Affiliation(s)
- M. Crespo Alonso
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| | - M. Arca
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| | - F. Isaia
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| | - R. Lai
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| | - V. Lippolis
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| | - S. K. Callear
- ISIS Facility
- Rutherford Appleton Laboratory
- Didcot, UK
| | - M. Caricato
- Department of Chemistry and INSTM Research Unit
- University of Pavia
- 27100 Pavia, Italy
| | - D. Pasini
- Department of Chemistry and INSTM Research Unit
- University of Pavia
- 27100 Pavia, Italy
| | - S. J. Coles
- UK National Crystallography Service
- Chemistry
- Faculty of Natural and Environmental Sciences
- University of Southampton
- Southampton, UK
| | - M. C. Aragoni
- Dipartimento di Scienze Chimiche e Geologiche
- Università degli Studi di Cagliari
- Cittadella Universitaria
- 09042 Monserrato Cagliari, Italy
| |
Collapse
|
26
|
Poggiogalle E, Polidoro G, Arca M, Lenzi A, Donini L. P116 Effects of nutrition, exercise and lifestyle interventions on ghrelin in obese children and adolescents. NUTR CLIN METAB 2013. [DOI: 10.1016/s0985-0562(13)70448-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
Pacifico L, Arca M, Anania C, Cantisani V, Di Martino M, Chiesa C. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013; 23:1010-1016. [PMID: 23018041 DOI: 10.1016/j.numecd.2012.08.003] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/07/2012] [Revised: 07/31/2012] [Accepted: 08/06/2012] [Indexed: 01/05/2023]
Abstract
BACKGROUND AND AIMS Lifestyle modification has been the mainstay of controlling childhood obesity and has proved to be effective in reducing cardiovascular risk factors. However, it is currently unknown whether the subclinical atherosclerotic changes associated with nonalcoholic fatty liver disease (NAFLD) in such population are reversible. METHODS AND RESULTS We analyzed changes of brachial flow-mediated dilation (FMD), carotid intima-media thickness (cIMT), clinical, laboratory, and imaging data in 120 obese children with NAFLD, at the end of a 1-year intervention program with diet and physical exercise. The lifestyle intervention led to a significant mean decrease of body mass index (BMI)-standard deviation score (SDS), waist circumference (WC) and fat mass, along with diastolic blood pressure, triglycerides, liver enzymes, insulin, insulin resistance (homeostasis model assessment of insulin resistance, HOMA-IR), and high-sensitivity C-reactive protein. At the end of the study, FMD improved (P < 0.0001), while cIMT did not change significantly (P = 0.20). A significant decrease in hepatic fat content as measured by magnetic resonance imaging was also observed. Changes in FMD were inversely associated with changes in BMI-SDS, WC, total cholesterol, non-HDL cholesterol, liver enzymes, HOMA-IR, physical activity, and hepatic fat content. After including in the model all the significant variables as well as age, gender, pubertal status, and baseline FMD values, changes in FMD were significantly and independently associated with changes in WC and total cholesterol. CONCLUSION Also in obese children with NAFLD arterial function may be restored by improving metabolic risk factors and reducing visceral adiposity following a 1-year lifestyle intervention.
Collapse
Affiliation(s)
- L Pacifico
- Department of Pediatrics and Child Neuropsichiatry, Sapienza University of Rome, Italy
| | | | | | | | | | | |
Collapse
|
28
|
Gianfagna F, Tamburrelli C, Vohnout B, Crescente M, Izzi B, Pampuch A, De Curtis A, Di Castelnuovo A, Cutrone A, Napoleone E, Tayo B, Lorenzet R, Nanni L, Arca M, Donati MB, de Gaetano G, Cerletti C, Iacoviello L. Heritability, genetic correlation and linkage to the 9p21.3 region of mixed platelet-leukocyte conjugates in families with and without early myocardial infarction. Nutr Metab Cardiovasc Dis 2013; 23:684-692. [PMID: 22633792 DOI: 10.1016/j.numecd.2012.02.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2011] [Revised: 02/02/2012] [Accepted: 02/27/2012] [Indexed: 11/25/2022]
Abstract
BACKGROUND AND AIMS Variations in mixed platelet-leukocyte conjugate formation in human whole blood could be genetically determined. We quantified platelet and leukocyte activation and interaction in families with or without early myocardial infarction and evaluated their heritability, genetic correlation and linkage to the 9p21.3 region. METHODS AND RESULTS The study population included 739 subjects (≥ 15 years old) from 54 large pedigrees, 23 with and 31 without familial myocardial infarction. Mixed platelet-leukocyte conjugates and markers of platelet or leukocyte activation (P-selectin, CD11b and L-selectin surface expression) were measured both before and after in vitro blood stimulation with collagen-ADP. All traits had significant genetic components (17.5-65.3% of the phenotypic variability), while shared household effects (0-39.6%) and environmental covariates (0-10.2%) tended to be smaller. Stimulated platelet-polymorphonuclear leukocyte (PMN) and platelet-monocyte conjugates showed the highest linkage to the 9p21.3 region (LOD = 0.94 and 1.33, respectively; empirical p value = 0.017 and 0.009). PMN markers resulted strongly genetically correlated between them in bivariate analysis among pairs of quantitative traits. CONCLUSION This study supports a genetic regulation of human mixed platelet-leukocyte conjugates.
Collapse
Affiliation(s)
- F Gianfagna
- Laboratory of Genetic and Environmental Epidemiology, Fondazione di Ricerca e Cura Giovanni Paolo II, Università Cattolica, Campobasso, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Spinelli F, Alessandri C, Marocchi E, Ceccarelli F, Capozzi A, Sorice M, Arca M, Pacelli M, Buttari B, Riganò R, Profumo E, Valesini G, Conti F. THU0175 T cell reactivity to β2 glycoprotein I in systemic lupus erythematosus and anti-phospholipid syndrome: Correlation with subclinical atherosclerosis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
30
|
Arca M, Bellot A, Dupont C, Bach N, Eckart P, Penniello-Valette MJ, Brouard J. [Two uncommon extrapulmonary forms of Mycoplasma pneumoniae infection]. Arch Pediatr 2013; 20:378-81. [PMID: 23453717 DOI: 10.1016/j.arcped.2013.01.020] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2012] [Revised: 09/11/2012] [Accepted: 01/22/2013] [Indexed: 11/25/2022]
Abstract
Mycoplasma pneumonia is the second most frequent bacterium in pneumonia and the leading intracellular type. M. pneumoniae pulmonary infection is characterized by a slower onset profile and a lower biological inflammatory picture than pneumococcal infection. Both upper and lower respiratory tracts are often affected and sometimes a Kawasaki-like syndrome can be associated, with conjunctivitis or cheilitis. Extrapulmonary forms of the disease can occur, whether or not it is associated with pulmonary infection. We report two cases: in the first case, a renal form of M. pneumoniae disease developed in a 6-year-old girl, with membranous proliferative glomerulonephritis expressed as a picture of impure nephritic syndrome with decreased serum complement concentration, following an upper respiratory infection. Diagnosis was obtained by means of a kidney biopsy. The second case occurred in an 8-year-old girl who expressed, after a respiratory tract infection, neurological symptoms such as ocular flutter, perception disorder, and ataxia. This onset is typical of post-infectious rhombencephalitis. Biological investigations and imaging were normal. In both cases, M. pneumoniae infection was diagnosed on the basis of immunoglobulin M-positive serology. Direct exploration of the bacterium was negative, due to its fragility and delayed diagnostic hypothesis. Several forms of M. pneumoniae infection are either the direct effect of the bacterium or are secondary to a cross-immunological reaction. As its frequency is increasing, M. pneumoniae infection should be raised as a cause of atypical, less well-known extrapulmonary forms of the disease.
Collapse
Affiliation(s)
- M Arca
- Service de pédiatrie, pôle femme-enfant-hématologie, CHU de Caen, avenue de la Côte-de-Nacre, 14000 Caen, France.
| | | | | | | | | | | | | |
Collapse
|
31
|
Pacifico L, Arca M, Anania C, Cantisani V, Di Martino M, Chiesa C. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012. [PMID: 23018041 DOI: 10.1016/j.numecd.2012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND AND AIMS Lifestyle modification has been the mainstay of controlling childhood obesity and has proved to be effective in reducing cardiovascular risk factors. However, it is currently unknown whether the subclinical atherosclerotic changes associated with nonalcoholic fatty liver disease (NAFLD) in such population are reversible. METHODS AND RESULTS We analyzed changes of brachial flow-mediated dilation (FMD), carotid intima-media thickness (cIMT), clinical, laboratory, and imaging data in 120 obese children with NAFLD, at the end of a 1-year intervention program with diet and physical exercise. The lifestyle intervention led to a significant mean decrease of body mass index (BMI)-standard deviation score (SDS), waist circumference (WC) and fat mass, along with diastolic blood pressure, triglycerides, liver enzymes, insulin, insulin resistance (homeostasis model assessment of insulin resistance, HOMA-IR), and high-sensitivity C-reactive protein. At the end of the study, FMD improved (P < 0.0001), while cIMT did not change significantly (P = 0.20). A significant decrease in hepatic fat content as measured by magnetic resonance imaging was also observed. Changes in FMD were inversely associated with changes in BMI-SDS, WC, total cholesterol, non-HDL cholesterol, liver enzymes, HOMA-IR, physical activity, and hepatic fat content. After including in the model all the significant variables as well as age, gender, pubertal status, and baseline FMD values, changes in FMD were significantly and independently associated with changes in WC and total cholesterol. CONCLUSION Also in obese children with NAFLD arterial function may be restored by improving metabolic risk factors and reducing visceral adiposity following a 1-year lifestyle intervention.
Collapse
Affiliation(s)
- L Pacifico
- Department of Pediatrics and Child Neuropsichiatry, Sapienza University of Rome, Italy
| | | | | | | | | | | |
Collapse
|
32
|
Arca M, Pigna G, Favoccia C. Management of statin-intolerant patient. Panminerva Med 2012; 54:105-118. [PMID: 22525565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Large scale clinical trials have undoubtedly demonstrated that statins are effective in reducing cardiovascular events and all-cause mortality in almost all patient populations. Also the short and long-term safety of statin therapy has been well established in the majority of treated patients. Nevertheless, intolerance to statins must be frequently faced in the clinical practice. The most commonly observed adverse effects of statins are muscle symptoms and elevation of hepatic aminotransferase and creatinine kinase (CK) levels. Overall, myalgia (muscle pain with or without plasma CK elevations) and a single abnormally elevated liver function test constitute approximately two-thirds of reported adverse events during statin therapy. These side effects raise concerns in the patients and are likely to reduce patient's adherence and, consequently, the cardiovascular benefit. Therefore, it is mandatory that clinicians improve knowledge on the clinical aspects of side effects of statins and the ability to manage patients with intolerance to statins. Numerous different approaches to statin-intolerant patients have been suggested, but an evidence-based consensus is difficult to be reached due to the lack of controlled trials. Therefore, it might be useful to review protocols and procedures to control statin intolerance. The first step in managing intolerant patients is to determine whether the adverse events are indeed related to statin therapy. Then, the switching to another statin or lower dosage, the alternate dosing options and the use of non-statin compounds may be practical strategies. However, the cardiovascular benefit of these approaches has not been established, so that their use has to be employed after a careful clinical assessment of each patient.
Collapse
Affiliation(s)
- M Arca
- Atherosclerosis Unit, Department of Internal Medicine and Allied Medical Specialities, La Sapienza University, Rome, Italy.
| | | | | |
Collapse
|
33
|
Bauleo L, Kirchmayer U, Belleudi V, Agabiti N, Pinnarelli L, Cascini S, Fusco D, Arca M, Davoli M. P2-141 Definition and validation of an algorithm to identify COPD patients from administrative databases. Br J Soc Med 2011. [DOI: 10.1136/jech.2011.142976i.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
Kirchmayer U, Belleudi V, Agabiti N, Martino MD, Bauleo L, Pinnarelli L, Fusco D, Arca M, Davoli M. P1-193 Two-years mortality after evidence based drug therapy of acute myocardial infarction: a population-based cohort study in Rome, Italy. Br J Soc Med 2011. [DOI: 10.1136/jech.2011.142976d.86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Pacifico L, Anania C, Martino F, Poggiogalle E, Chiarelli F, Arca M, Chiesa C. Management of metabolic syndrome in children and adolescents. Nutr Metab Cardiovasc Dis 2011; 21:455-466. [PMID: 21565479 DOI: 10.1016/j.numecd.2011.01.011] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2010] [Revised: 01/17/2011] [Accepted: 01/19/2011] [Indexed: 02/06/2023]
Abstract
Concomitantly with the increasing prevalence of childhood obesity, the prevalence of metabolic syndrome (MS) is rising among children and adolescents, leading to fears for future epidemics of type 2 diabetes mellitus and cardiovascular disease in the young. This makes the accurate identification and the appropriate treatment of children and adolescents with MS an important priority for health care systems. This review will focus on the management of each component of MS, including the nonalcoholic fatty liver disease (NAFLD), which is currently considered as the hepatic component of the syndrome. The most relevant target of treatment of MS in children and adolescents is the abdominal obesity. To this end, we will discuss the efficacy of dietary approaches, possibly coupled with regular physical activity, on eliciting visceral fat reduction. We will also highlight several aspects of the treatment of the high triglyceride/low high-density lipoprotein cholesterol phenotype, including the use of non-pharmacological measures, and indications for instituting drug therapies. Part of this review will address treatment of glucose abnormalities, including the benefits of lifestyle modification alone, and the potential adjunctive role of hypoglycemic drugs. The treatment of hypertension in children with MS also requires a multifaceted approach and the available data of this topic will be examined. The remainder of this review will address treatment to reverse NAFLD and prevent progression to end-stage disease.
Collapse
Affiliation(s)
- L Pacifico
- Department of Pediatrics, La Sapienza University of Rome, 00161 Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
36
|
Arca M, Pigna G, Zaccagna F, Cavallo Marincola B, Montali A, Iuliano L, Napoli A, Catalano C. P9 ATHEROSCLEROTIC BURDEN IN ASYMPTOMATIC PATIENTS WITH METABOLIC SYNDROME EVALUATED BY COMPUTED TOMOGRAPHY ANGIOGRAPHY. ATHEROSCLEROSIS SUPP 2010. [DOI: 10.1016/s1567-5688(10)70076-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
37
|
Paoletti V, Loricchio DP, Basili S, Cavina G, Labaddia G, Pacelli M, Arca M, Mammarella A. [Lifestyle and global cardiovascular risk: a prospective study on a borderline hypertensive population]. Clin Ter 2010; 161:13-23. [PMID: 20393673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
BACKGROUND AND AIMS Arterial hypertension is a well known risk factor for cardiovascular diseases. Today, it is possible to calculate the cardiovascular risk at 10 years with the risk card. The reduction of cardiovascular risk is based on a multi-factorial approach including the lifestyle modification. In Italy, OEC study has calculated that a certain proportion of borderline hypertensives, not eligible for a pharmacological treatment, remain at risk. Borderline arterial hypertension (140-150/90-95 mmHg) in Italian population is documented in 19% of males and 14% of females.: Aim of the study is to examine the efficacy of the lifestyle changes in reducing the global cardiovascular risk in bordeline hypertensives. MATERIALS AND METHODS 102 patients affected by borderline hypertensive (46 M and 56 F, mean age: 55.6 yrs ) were enclosed in a 12 months prospective study. Three checks were programmed during the follow-up, i.e., at beginning, 6 months and 12 months later. At the start of the study every patient received a list of lifestyle changes to be respected. Pressure arterial systolic and diastolic were obtained at beginning and at the end of successive. At the last check each patient received a questionnaire to be filled up. According to the calculated score, each patient was classified as: non-responder (score: 0-3), partially responder (score: 4-6), responder (score: 7-9). RESULTS A significant reduction of the globalcardiovascular risk has been observed at the end of the study in both the responders and partially responders. Such a reduction was seen to be due to positive changes in blood pressure and total, HDL, LDL cholesterol. CONCLUSIONS This study confirmed that a non-pharmacological therapy based on lifestyle changes has to be preventively administered in the presence of a borderline hypertension because of its beneficial effects in reducing the global risk of cardiovascular disease. Therefore, we firmly think that a prompt utilization of a correct lifestyle can sort the triple effect of improving the expectancy of life, ameliorating the quality of life, reducing the social costs of arterial hypertension.
Collapse
Affiliation(s)
- V Paoletti
- Dipartimento di Discipline Chirurgiche e Metodologie Integrate, Universitegli Studi di Genova, Italia.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Arca M, Cambuli VM, Montali A, Sentinelli F, Filippi E, Campagna F, Quagliarini F, Antonini R, Romeo S, Baroni MG. Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment. Nutr Metab Cardiovasc Dis 2009; 19:660-666. [PMID: 19632099 DOI: 10.1016/j.numecd.2008.11.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/25/2008] [Revised: 11/12/2008] [Accepted: 11/13/2008] [Indexed: 10/20/2022]
Abstract
BACKGROUND AND AIMS Hypoadiponectinemia has been reported in patients with familial combined hyperlipidemia (FCHL) presenting increased waist circumference and insulin resistance. However, no studies have evaluated this association in non-obese FCHL patients. Moreover, it is unclear whether correction of lipoprotein abnormalities may influence adiponectin levels in FCHL. METHODS AND RESULTS We have compared serum levels of adiponectin in 199 non-obese FCHL patients (BMI 25.96+/-3.7), 116 normolipaemic (NL) non-affected relatives (BMI 24.4+/-4.0) and 192 controls (BMI 28.0+/-7.4). In a subgroup of FCHL patients, changes in adiponectin levels after treatment with atorvastatin (n=22) or fenofibrate (n=26) were also evaluated. FCHL patients as well as their NL relatives showed lower serum adiponectin levels compared to controls (9.7+/-5.4 microg/mL, 10.7+/-5.3 microg/mL and 17.3+/-13.7microg/mL, respectively; p<0.0001 for all comparisons). After controlling for confounders, the strongest association with hypoadiponectinemia was observed with family history of FCHL, followed by HDL-C (negatively) and age (positively). These variables jointly explained 15% of the total variance of serum adiponectin levels. After 24-week of treatment, adiponectin was increased by 12.5% (p<0.05) by atorvastatin and was reduced by 10% by fenofibrate, resulting in a treatment difference of 22.5% in favor of atorvastatin (p<0.017). CONCLUSIONS FCHL patients showed lower serum adiponectin levels compared to controls. Also normolipaemic relatives of FCHL patients presented decreased levels of adiponectin, suggesting a possible common background in the determination of this abnormality. Overall, these observations indicate that hypoadiponectinemia may be an inherent characteristic of the FCHL phenotype. In FCHL patients hypoadiponectinemia may be partially corrected by atorvastatin but not by fenofibrate treatment.
Collapse
Affiliation(s)
- M Arca
- Department of Clinical and Medical Therapy, Unit of Medical Therapy, University La Sapienza of Rome, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161 Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Conti B, Montali A, Valiante S, Gaudio C, Panetta G, Pergolini A, Antonini R, Violi F, Campagna F, Arca M. PO5-111 C242T POLYMORPHISM OF NADPH OXIDASE P22PHOX GENE PREDICTS MAJOR CARDIOVASCULAR EVENTS (MACE) IN HIGH-RISK INDIVIDUALS. ATHEROSCLEROSIS SUPP 2007. [DOI: 10.1016/s1567-5688(07)71121-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
40
|
Abbati GL, Aragoni MC, Arca M, Isaia F, Lippolis V. X-RAY CRYSTAL STRUCTURE AND INFRARED SPECTRUM OF THE MONOCLINIC FORM OF DICHLOROBIS- (N, N'-DIETHYLTHIOUREA)COBALT(II). J COORD CHEM 2006. [DOI: 10.1080/00958979908024544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- G. L. Abbati
- a Dipartimento di Chimica , via G. Campi 183, 41100 , Modena , Italy
| | - M. C. Aragoni
- a Dipartimento di Chimica , via G. Campi 183, 41100 , Modena , Italy
| | - M. Arca
- b Dipartimento di Chimica e Tecnologie , Inorganiche e Metallorganiche , via Ospedale 72, 09124 , Cagliari , Italy
| | - F. Isaia
- b Dipartimento di Chimica e Tecnologie , Inorganiche e Metallorganiche , via Ospedale 72, 09124 , Cagliari , Italy
| | - V. Lippolis
- b Dipartimento di Chimica e Tecnologie , Inorganiche e Metallorganiche , via Ospedale 72, 09124 , Cagliari , Italy
| |
Collapse
|
41
|
Arca M, Sirinian I, Campagna F, Belleudi F, Garofano T, Sorice M, Torrisi M. We-W43:2 Adaptor proteins a novel mechanism for the regulation of lipoprotein receptors: The case of autosomal recessive hypercholesterolemia (ARH) protein and LDLR. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)81317-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
42
|
Montali A, Antonini T, Bifolco M, Campagna F, Pigna G, Cantini R, Antonini R, Arca M. Th-P16:412 Efficacy and safety of atorvasatin vs.fenofibrate in familial combined hyperlipidemia (FCHL). A randomized, pilot, comparative study. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)82370-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Cavallo MG, Montali A, Monetini L, Valente L, Mariani P, Bifolco M, Sirinian MI, Antonini TM, Fioretti F, Campagna F, Verna R, Arca M. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL). Nutr Metab Cardiovasc Dis 2005; 15:262-269. [PMID: 16054550 DOI: 10.1016/j.numecd.2004.08.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2004] [Revised: 08/24/2004] [Accepted: 08/24/2004] [Indexed: 11/18/2022]
Abstract
BACKGROUND AND AIM Familial combined hyperlipidemia (FCHL) is a genetic disorder of lipid metabolism associated with insulin resistance and abnormalities in fatty acid metabolism whose underlying mechanisms are largely unknown. Perturbations in the TNFalpha/TNF-R pathway may play a role in these abnormalities. METHODS AND RESULTS We determined plasma levels of TNFalpha and sTNF-R p75 in 85 FCHL patients (TC 245+/-45 mg/dl; TG 260+/-148 mg/dl; apoB 148+/-37 mg/dl) and in 29 age- and sex-matched normolipemic relatives (NL) (TC 187+/-22.8 mg/dl; TG 115+/-37 mg/dl; apoB 106+/-16 mg/dl). Thirty-four normolipemic subjects (TC 180+/-34 mg/dl; TG 107+/-42 mg/dl; apoB 95+/-22 mg/dl) were also included as unrelated controls (NC). Plasma free fatty acids (NEFA) were also measured and insulin sensitivity was evaluated by HOMA. Levels of sTNF-R p75 were significantly reduced in FCHL compared to NL (2.30+/-0.55 ng/ml vs. 2.64+/-0.88 ng/ml, p<0.05) but not compared to NC (2.35+/-0.68 ng/ml). HOMA values were comparable in all groups and did not show any relation with plasma levels of sTNF-R p75. Logistic analysis demonstrated that a low concentration of sTNF-R p75 was an independent predictor of the affected status within FCHL families, but this role was no longer evident when FCHL patients were compared to NC. In FCHL, age (p<0.001) was positively, and TG (p=0.029) and HDL-C (p=0.025) were negatively correlated with plasma concentrations of sTNF-R p75. In the other groups, age (in NL) and non-HDL-C (in NC) were significantly correlated with sTNF-R p75. CONCLUSIONS Although our data do not support a causative role of TNFalpha/TNF-R alterations in FCHL, they confirm that variation in TNF-R shedding may influence lipid phenotypic expression in FCHL families.
Collapse
Affiliation(s)
- M G Cavallo
- Dipartimento di Clinica e Terapia Medica Applicata, Università di Roma La Sapienza, Policlinico Umberto I, Viale del Policlinico, 155, 00161 Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJP. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005; 111:278-87. [PMID: 15655129 DOI: 10.1161/01.cir.0000153341.46271.40] [Citation(s) in RCA: 221] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Several studies have reported that the cholesteryl ester transfer protein (CETP) TaqIB gene polymorphism is associated with HDL cholesterol (HDL-C) levels and the risk of coronary artery disease (CAD), but the results are inconsistent. In addition, an interaction has been implicated between this genetic variant and pravastatin treatment, but this has not been confirmed. METHODS AND RESULTS A meta-analysis was performed on individual patient data from 7 large, population-based studies (each >500 individuals) and 3 randomized, placebo-controlled, pravastatin trials. Linear and logistic regression models were used to assess the relation between TaqIB genotype and HDL-C levels and CAD risk. After adjustment for study, age, sex, smoking, body mass index (BMI), diabetes, LDL-C, use of alcohol, and prevalence of CAD, TaqIB genotype exhibited a highly significant association with HDL-C levels, such that B2B2 individuals had 0.11 mmol/L (0.10 to 0.12, P<0.0001) higher HDL-C levels than did B1B1 individuals. Second, after adjustment for study, sex, age, smoking, BMI, diabetes, systolic blood pressure, LDL-C, and use of alcohol, TaqIB genotype was significantly associated with the risk of CAD (odds ratio=0.78 [0.66 to 0.93]) in B2B2 individuals compared with B1B1 individuals (P for linearity=0.008). Additional adjustment for HDL-C levels rendered a loss of statistical significance (P=0.4). Last, no pharmacogenetic interaction between TaqIB genotype and pravastatin treatment could be demonstrated. CONCLUSIONS The CETP TaqIB variant is firmly associated with HDL-C plasma levels and as a result, with the risk of CAD. Importantly, this CETP variant does not influence the response to pravastatin therapy.
Collapse
Affiliation(s)
- S M Boekholdt
- Department of Cardiology, Academic Medical Center, Academic Medical Center, Amsterdam, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Gaudio C, Tanzilli G, Vittore A, Arca M, Barillà F, Di Michele S, Minardi G, Fedele F, Lombardi M, Donato L. Detection of coronary artery stenoses using breath-hold magnetic resonance coronary angiography. Comparison with conventional x-ray angiography. Eur Rev Med Pharmacol Sci 2004; 8:121-8. [PMID: 15368796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
PURPOSE To detect coronary artery stenoses, we compare breath-hold magnetic resonance coronary angiography (MRCA) to conventional coronary angiography (CA). MATERIALS AND METHODS Sixty-five patients with suspected coronary artery disease underwent MRCA and CA within one week. MRCA examination was performed by using the two-dimensional (2D) breath-hold technique with a fast spoil gradient-echo sequence/spiral. Each imaging sequence was obtained within one breath-hold in expiration (14 seconds of apnoea). The assessment of coronary artery stenoses on magnetic resonance (MR) angiograms was independently performed by two blinded readers and compared to conventional CA images. RESULTS Three hundred and ninety segments were evaluated by the two imaging techniques. MRCA correctly detected 76 of 88 (86%) stenoses, and recognized 242 of 302 (80%) not affected segments. The Pearson correlation coefficient between MRCA and CA in assessing coronary narrowings was very high: r = 0.85. Despite this the mean difference was 4.5 with a standard error of estimate of 0.21, indicating that MRCA slightly overestimates the degree of stenoses. CONCLUSIONS Our study showed that 2D breath-hold MRCA is an accurate technique in displaying and quantifying the most significant stenoses in the proximal and middle segments of the coronary arteries.
Collapse
Affiliation(s)
- C Gaudio
- Department of Cardiology, La Sapienza University of Rome - Rome (Italy)
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Bertolini S, Calabresi L, Pisciotta L, Balboni M, Arca M, Cantafora A, Franceshini G, Calandra S. W14.347 Mutations in LCAT gene causing familial LCAT deficiency, fish eye disease and co-dominant familial HDL deficiency. ATHEROSCLEROSIS SUPP 2004. [DOI: 10.1016/s1567-5688(04)90346-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Romaniello P, Aragoni MC, Arca M, Cassano T, Denotti C, Devillanova FA, Isaia F, Lelj F, Lippolis V, Tommasi R. Ground and Excited States of [M(H2timdt)2] Neutral Dithiolenes (M = Ni, Pd, Pt; H2timdt = Monoanion of Imidazolidine-2,4,5-trithione): Description within TDDFT and Scalar Relativistic (ZORA) Approaches. J Phys Chem A 2003. [DOI: 10.1021/jp034758r] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Pina Romaniello
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - M. C. Aragoni
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - M. Arca
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - T. Cassano
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - C. Denotti
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - F. A. Devillanova
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - F. Isaia
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - Francesco Lelj
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - V. Lippolis
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| | - R. Tommasi
- LAMI Dipartimento di Chimica and LASCAMM-INSTM Sezione Basilicata, Universitá della Basilicata, Via N. Sauro, 85100 Potenza, Italy, Dipartimento di Chimica Inorganica ed Analitica, S.S. 554 Bivio per Sestu, 09042 Monserrato-Cagliari, Italy, and Dipartimento di Fisica, Via G. Amendola 173, 1-70126 Bari, Italy
| |
Collapse
|
48
|
Fellin R, Zuliani G, Arca M, Pintus P, Pacifico A, Montali A, Corsini A, Maioli M. Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH). Nutr Metab Cardiovasc Dis 2003; 13:278-286. [PMID: 14717060 DOI: 10.1016/s0939-4753(03)80032-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND AIM Inherited hypercholesterolemias are common disorders characterised by elevated LDL-C levels and premature coronary heart disease. We have recently described a recessive form of hypercholesterolemia (autosomal recessive hypercholesterolemia, ARH) in which LDL catabolism is reduced because of a mutation in the gene coding for an adaptor protein that impairs LDL-receptor (LDL-R) activity in the liver. The aim of this study was to characterise in detail the phenotypes of subjects with homozygous and heterozygous ARH. METHODS AND RESULTS We have so far identified six Italian families with ARH and studied the clinical and biochemical characteristics of 11 homozygotes (age 13-47 years) and 12 obligate heterozygotes (age 42-83 years). The study protocol included an evaluation of the lipoprotein profile, LDL-R activity in fibroblasts, LDL binding activity, and apo E genotype; a structured questionnaire (CHD risk factors, medical history, current medications); a physical examination, resting and stress ECG, ultrasound examinations (heart, carotid arteries, Achilles tendons) and coronary angiography. The pedigrees were characterised by the absence of vertical transmission; consanguinity was documented in two families. Only the two previously described Sardinian mutations, ARH1 (c.432insA) and ARH2 (c.65G > A), were identified in the probands. All of the ARH homozygotes had large tendinous xanthomas, two had exertional angina, and four a positive stress ECG. None had experienced myocardial infarction or stroke. More than half had instrumental signs of atherosclerosis such as a positive stress ECG or positive carotid echo-doppler examination. The ARH heterozygotes were consistently normal and had a normal lipid profile. CONCLUSIONS The ARH phenotype resembles that of familial hypercholesterolemia (FH) homozygotes, but ARH may be a less serious illness. The absence of vertical transmission, and the presence of mild coronary heart disease and consanguinity, can suggest a possible diagnosis of ARH. ARH might be considered a phenocopy of FH but heterozygous subjects seem to have a consistently normal phenotype.
Collapse
Affiliation(s)
- R Fellin
- Second Department of Internal Medicine, University of Ferrara, Ferrara, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Cassano T, Tommasi R, Nitti L, Aragoni MC, Arca M, Denotti C, Devillanova FA, Isaia F, Lippolis V, Lelj F, Romaniello P. Picosecond absorption saturation dynamics in neutral [M(R,R′timdt)2] metal-dithiolenes. J Chem Phys 2003. [DOI: 10.1063/1.1556612] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
50
|
Arca M, Ombres D, Montali A, Campagna F, Mangieri E, Tanzilli G, Campa PP, Ricci G, Verna R, Pannitteri G. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population. Eur J Clin Invest 2002; 32:9-15. [PMID: 11851721 DOI: 10.1046/j.1365-2362.2002.00935.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND The present study evaluated the role of the PON1 L55M polymorphism independently and in conjunction with the Q192R polymorphism on the risk of coronary atherosclerosis in an Italian population. MATERIALS AND METHODS Three hundred and ninety-one subjects with significant coronary stenosis (> 50%) (coronary artery disease-positive; CAD+), 196 subjects with normal coronary arteries (< 10% stenosis) (CAD-) and 178 healthy controls were screened using a combination of polymerase chain reaction and restriction enzyme digestion. RESULTS In the pooled population, the frequencies of L and M alleles were 0.63 and 0.37, respectively; the most common haplotypes were QQ/LM (24.2%) and QR/LL (21.8%) and a strong linkage disequilibrium between L/55 and R/192 alleles was observed (D' = -0.91; P < 0.0001). CAD+ subjects did not show any significant differences in the distribution of PON1-55 genotypes as compared to CAD- subjects and population controls (chi2 = 1.5, P = 0.8). After controlling for other risk factors, the low-concentration M allele was not associated with a significant change of CAD risk (OR 1.02; 95% CI 0.80-1.29; P = 0.87). Moreover, the L55M polymorphism did not show any interaction with other risk factors such as smoking, diabetes, hypertension, low levels of high-density lipoprotein (HDL) or high ratios of low-density to high-density lipoproteins. The combination of L55M with the Q192R polymorphism did not show any effect on CAD risk. However, a marginal decrease in myocardial infarction risk was detected when QQ/MM carriers (OR 0.51; 95% CI 0.26-0.99; P = 0.048), but not LL/RR carriers, were compared with subjects not homozygous for an L or R allele. CONCLUSIONS These findings did not indicate a major effect of the PON1 L55M polymorphism, either alone or in combination with the Q192R polymorphism, on CAD risk. Additional studies are needed for a better evaluation of the role of the 55/192 PON1 genotypes in combination on myocardial infarction risk.
Collapse
Affiliation(s)
- M Arca
- Università degli Studi di Roma 'La Sapienza', Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|